Karoo’s mission is to lead the commercial translation of state of the art UK gene therapies and revolutionise the future of human healthcare. While targeted initially at inherited diseases, Karoo’s vision is ultimately the transformative treatment of devastating common diseases such as heart disease and dementia.
In partnership with eXmoor Pharma we are building the expertise and infrastructure necessary to advance development of gene therapies from discovery to patient.
We provide a fully-integrated service to industry and academic programs, from process review and development, to GLP and GMP manufacturing, through to clinical development and regulatory approval. Our goal is to become the UK's premier national manufacturing facility.
We also in-licence novel gene therapies and fund them along our conveyor belt - all the way from early academic promise to the clinic.